HAE
HAEMONETICS CORP
+3.51 (+3.30%)109.75USD158K成交股數5.0B市值53.0本益比(近四季)3.7股價營收比+5.6%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 4 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 27Q1 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 339M+3% | 339M-3% | 327M-5% | 321M-4% | 331M-2% | 349M+10% | 346M+11% | 336M+10% | 336M | 318M | 311M | 304M |
| 營業成本 | 137M | 137M | 133M | 129M | 138M | 155M | 158M | 161M | 158M | 148M | 144M | 148M |
| 毛利 | 203M+5% | 202M+5% | 195M+4% | 192M+10% | 193M+9% | 194M+14% | 187M+12% | 175M+12% | 178M | 171M | 167M | 156M |
| 毛利率 | 59.8% | 59.7% | 59.5% | 59.8% | 58.4% | 55.5% | 54.2% | 52.0% | 52.9% | 53.6% | 53.7% | 51.3% |
| 研發費用 | 16.2M | 14.2M | 14.9M | 16.3M | 18.3M | 15.8M | 14.1M | 14.4M | 13.3M | 12.7M | 12.6M | 15.6M |
| 銷售管理費用 | 119M | 109M | 102M | 111M | 115M | 106M | 107M | 108M | 112M | 115M | 93.5M | 97.8M |
| 營業利益 | 57.5M-19% | 67.4M+14% | 58.5M+13% | 53.9M+36% | 71.3M+55% | 59.0M+67% | 51.7M-4% | 39.8M+13% | 46.0M | 35.3M | 53.7M | 35.3M |
| 營業利益率 | 16.9% | 19.9% | 17.9% | 16.8% | 21.6% | 16.9% | 15.0% | 11.8% | 13.7% | 11.1% | 17.2% | 11.6% |
| 稅後淨利 | 33.0M-130% | 44.7M+19% | 38.7M+14% | 34.0M-11% | −110M-451% | 37.5M+51% | 33.8M-18% | 38.4M+31% | 31.2M | 24.9M | 41.0M | 29.4M |
| 淨利率 | 9.7% | 13.2% | 11.8% | 10.6% | -33.1% | 10.8% | 9.8% | 11.4% | 9.3% | 7.8% | 13.2% | 9.7% |
| 稀釋 EPS | 0.72-38% | 0.95+28% | 0.81+23% | 0.70-5% | 1.17+92% | 0.74+54% | 0.66-18% | 0.74+28% | 0.61 | 0.48 | 0.80 | 0.58 |
| 稀釋股數 | 45.7M | 47.0M | 47.7M | 48.4M | 50.7M | 50.6M | 51.2M | 51.6M | 51.4M | 51.4M | 51.3M | 51.4M |
資產負債表 期末餘額
| 科目 | 27Q1 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 223M | 363M | 296M | 293M | 307M | 321M | 299M | 344M | 194M | 351M | 286M | 284M |
| 應收帳款 | 216M | 196M | 207M | 201M | 203M | 212M | 214M | 201M | 212M | 174M | 177M | 179M |
| 存貨 | 307M | 321M | 336M | 361M | 365M | 360M | 382M | 374M | 304M | 286M | 289M | 259M |
| 總資產 | 2.4B | 2.5B | 2.4B | 2.5B | 2.5B | 2.5B | 2.5B | 2.5B | 2.2B | 2.0B | 2.0B | 1.9B |
| 有息負債 | 1.2B | 920M | 920M | 921M | 921M | 1.2B | 1.2B | 1.2B | 857M | 749M | 751M | 754M |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 837M | 911M | 849M | 882M | 821M | 907M | 879M | 905M | 943M | 894M | 865M | 818M |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | −946M | −557M | −624M | −628M | −614M | −899M | −920M | −874M | −663M | −398M | −466M | −470M |
現金流量表 單季
| 科目 | 27Q1 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | 52.3M | – | – | 17.4M-163% | – | – | – | −27.4M | – | – | 19.1M | – |
| 資本支出 | 7.9M | – | – | 3.8M | – | – | – | 5.7M | – | – | 7.7M | – |
| 自由現金流 | 44.4M | – | – | 13.6M-141% | – | – | – | −33.1M | – | – | 11.4M | – |
| 折舊攤銷 | 27.1M | 27.4M | 28.3M | 28.8M | 28.2M | 29.0M | 29.2M | 29.1M | – | – | 23.0M | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | 13.1% | – | – | 4.2% | – | – | – | -9.8% | – | – | 3.7% | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 1.4B
| Hospital | 564M | 41.5% | +23.7% |
|---|---|---|---|
| Plasma | 535M | 39.3% | -6.0% |
| Blood Center | 261M | 19.2% | -7.8% |
地區2025 年度 · 1.2B
| 美國 | 1.0B | 85.3% | +4.2% |
|---|---|---|---|
| 亞洲 | 92.3M | 7.8% | -14.2% |
| 日本 | 62.4M | 5.3% | +7.4% |
| Other Countryor Region | 19.5M | 1.6% | +47.1% |
| 歐洲 小計 | 176M | 14.8% | +9.7% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | 1.3B | -2.0% | 97K | 0.0% | 2.05 | 260M |
| FY2025 | 1.4B | +4.0% | 168K | 0.0% | 3.31 | 142M |
| FY2024 | 1.3B | +12.0% | 118M | 9.0% | 2.29 | 144M |
| FY2023 | 1.2B | +17.7% | 115M | 9.9% | 2.24 | 81.7M |
| FY2022 | 993M | +14.1% | 43.4M | 4.4% | 0.84 | 75.8M |
| FY2021 | 870M | -11.9% | 79.5M | 9.1% | 1.55 | 71.8M |
| FY2020 | 988M | +2.2% | 76.5M | 7.7% | 1.48 | 109M |
| FY2019 | 968M | – | 55.0M | 5.7% | 1.04 | 40.3M |